Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Plants (Basel) ; 11(18)2022 Sep 19.
Artigo em Inglês | MEDLINE | ID: mdl-36145841

RESUMO

Alpha-mangostin (α-MN) is a xanthone obtained from Garcinia mangostana that has diverse anti-oxidative and anti-inflammatory potentials. However, its pharmacological activity against autoimmune hepatitis (AIH) has not been investigated before. Concanavalin A (Con A) was injected into mice to induce AIH and two doses of α-MN were tested for their protective effects against Con A-induced AIH. The results demonstrated the potent hepatoprotective activity of α-MN evidenced by a remarkable decrease of serum indices of the hepatic injury and amendment of the histological lesions. α-MN significantly attenuated the level and immuno-expression of myeloperoxidase (MPO) indicating a decrease in the neutrophil infiltration into the liver. Additionally, the recruitment of the CD4+ T cell was suppressed in the α-MN pre-treated animals. α-MN showed a potent ability to repress the Con A-induced oxidative stress evident by the reduced levels of malondialdehyde (MDA), 4-hydroxynonenal (4-HNE), and protein carbonyl (PC), as well as the enhanced levels of antioxidants as the reduced glutathione (GSH), superoxide dismutase (SOD), and total antioxidant capacity (TAC). The ELISA, RT-PCR, and IHC analyses revealed that α-MN enhanced the sirtuin1/nuclear factor erythroid 2 related factor-2 (SIRT1/Nrf2) signaling and its downstream cascade genes concurrently with the inhibition of the nuclear factor kappa B (NF-κB) and the inflammatory cytokines (tumor necrosis factor-alpha and interleukine-6) signaling. Taken together, these results inferred that the hepatoprotective activity of α-MN could prevent Con A-induced AIH through the modulation of the SIRT1/Nrf2/NF-κB signaling. Hence, α-MN may be considered as a promising candidate for AIH therapy.

2.
J Ethnopharmacol ; 292: 115223, 2022 Jun 28.
Artigo em Inglês | MEDLINE | ID: mdl-35354089

RESUMO

ETHNOPHARMACOLOGICAL RELEVANCE: Cucurbitacins are highly oxygenated tetracyclic triterpenoids, that represent the major metabolites reported from C. colocynthis (L.) Schrad.. Cucurbitacin E glucoside (CuE) is a tetracyclic triterpene glycoside separated from Cucurbitaceae plants. CuE has potent anti-inflammatory, immunomodulatory, and anti-tumor properties. AIM OF THE STUDY: The current study aimed at examining the hepatoprotective effect of CuE against concanavalin A (Con A)-produced hepatitis. MATERIALS AND METHODS: Mice were intravenously administered Con A (15 mg/kg) to induce AIH. CuE was orally administered at two different doses for five days preceding Con A injection. RESULTS: The results revealed that CuE pretreatment markedly attenuated the serum indices of hepatotoxicity and the severity of hepatic lesions. CuE depressed Con A-provoked increment in CD4+ T-cells in hepatic tissue. The antioxidant activity of CuE was evident through its ability to decrease markers of Con A-induced oxidative stress (malondialdehyde, 4-hydroxyenonanal, and protein carbonyl) and intensified the antioxidants in the hepatic tissue (SOD, GSH, and TAC). CuE increased mRNA expression of SIRT1 and Nrf2 as well as its binding capacity. Subsequently, CuE augmented mRNA expression of Nrf2 targeted genes as NQO1, GCL, and HO-1 and recovered its normal level. CuE inhibited the activation of NF-κB/downstream pro-inflammatory mediators signaling. Furthermore, CuE attenuated the mRNA expression of NLRP3 and its associated genes. CONCLUSION: Collectively, these results demonstrated the remarkable hepatoprotective potential of CuE towards Con A-induced AIH which was mediated via suppression of oxidative stress, enhancing SIRT1/Nrf2/HO-1, and prohibition of the NF-κB/NLRP3 signaling. CuE could be a candidate for hepatitis patients.


Assuntos
Hepatite , Triterpenos , Animais , Antioxidantes/metabolismo , Antioxidantes/farmacologia , Antioxidantes/uso terapêutico , Concanavalina A/metabolismo , Concanavalina A/farmacologia , Glucosídeos/farmacologia , Humanos , Camundongos , Fator 2 Relacionado a NF-E2/genética , Fator 2 Relacionado a NF-E2/metabolismo , NF-kappa B/metabolismo , Proteína 3 que Contém Domínio de Pirina da Família NLR/genética , Proteína 3 que Contém Domínio de Pirina da Família NLR/metabolismo , Estresse Oxidativo , RNA Mensageiro/metabolismo , Transdução de Sinais , Sirtuína 1/genética , Sirtuína 1/metabolismo , Triterpenos/química , Triterpenos/farmacologia , Triterpenos/uso terapêutico
3.
J Ethnopharmacol ; 281: 114552, 2021 Dec 05.
Artigo em Inglês | MEDLINE | ID: mdl-34438028

RESUMO

ETHNOPHARMACOLOGICAL RELEVANCE: Kirenol (Kr) is an ent-pimarane type diterpenoid that has been reported from Siegesbeckiaorientalis, S. pubescens, and S. glabrescens (family Asteraceae). These plants have been used traditionally for treating various ailments such as hypertension, neurasthenia, rheumatoid arthritis, asthma, snakebites, allergic disorders, paralysis, soreness, cutaneous disorders, rubella, menstrual disorders, numbness of limbs, dizziness, headache, and malaria. Importantly, in recent years, Kr has received great attention due to its diversified pharmacological activities. AIM OF THE STUDY: The current work aims to give an overview on the reported pharmacological activities of Kr. Furthermore, the findings regarding its methods for extraction, quantitative analysis, purification, pharmacokinetics, pharmaceutical and food preparations, biosynthesis, identification, semisynthetic analogues, and toxicity are highlighted to provide a reference and perspective for its further investigation. METHODS: Electronic databases including ScienceDirect, Web of Knowledge, SCOPUS, Wiley Online Library, Taylor & Francis, PubMed, Springer, JACS, and Google Scholar were searched up to the beginning of 2021 to identify the reported studies. RESULTS: A total of 93 articles have been reviewed. The reported data suggested that Kr possessed various bioactivities including cytotoxic, apoptotic, anticancer, anti-inflammatory, cardio-protective, anti-photo-aging, anti-adipogenic, antimicrobial, muscle function improvement, fracture and wound healing, and anti-arthritic. In addition, studies revealed that the antioxidative and anti-inflammatory activities of Kr may mediate many of its therapeutic potentials as confirmed by several in-vitro and in-vivo studies. CONCLUSION: This review provides an updated summary of the recent studies on Kr, including methods for extraction, quantitative analysis, purification, pharmacokinetics, pharmaceutical and food preparations, biosynthesis, and identification, as well as semisynthetic analogues, pharmacological activities, and toxicity. Thus, this work can provide useful considerations for planning and design future research on Kr.


Assuntos
Asteraceae/química , Diterpenos/química , Diterpenos/farmacologia , Asteraceae/metabolismo , Diterpenos/metabolismo , Humanos , Estrutura Molecular
4.
Food Funct ; 9(6): 3291-3300, 2018 Jun 20.
Artigo em Inglês | MEDLINE | ID: mdl-29790527

RESUMO

Garcinia mangostana L. (GM, family Guttiferae) is one of the most widely recognized tropical fruits. GM is a wealthy pool of xanthones that exhibit a wide range of bioactivities. Tovophyllin A (TA) separated from GM pericarps was tested for its efficacy to ameliorate acetaminophen (APAP)-induced liver injury. Mice were injected with a single dose of APAP with or without TA pretreatment. The protective effects of TA against APAP-induced liver damage were evident through amelioration of serum indices of hepatotoxicity and improvement of hepatic histopathologic lesions. TA has antioxidant activity because it inhibited APAP-induced lipid peroxidation and improved the antioxidant capacity of the liver. Also, TA enhanced the mRNA expression of nuclear erythroid-related factor 2 (Nrf2) and its target genes. Protein expression of Nrf2 and heme oxygenase-1 was enhanced remarkably in TA-pretreated groups. TA suppressed activation of nuclear factor-kappa B (NF-κB) and the subsequent release of pro-inflammatory cytokines. In conclusion, TA has a marked protective activity against APAP-induced hepatotoxicity which may be linked to its ability to activate Nrf2 and inhibit the NF-κB signaling pathway.


Assuntos
Acetaminofen/efeitos adversos , Doença Hepática Induzida por Substâncias e Drogas/prevenção & controle , Garcinia mangostana/química , Fator 2 Relacionado a NF-E2/metabolismo , Extratos Vegetais/administração & dosagem , Xantonas/farmacologia , Animais , Doença Hepática Induzida por Substâncias e Drogas/etiologia , Doença Hepática Induzida por Substâncias e Drogas/genética , Doença Hepática Induzida por Substâncias e Drogas/metabolismo , Frutas/química , Humanos , Fígado/efeitos dos fármacos , Fígado/metabolismo , Masculino , Camundongos , Fator 2 Relacionado a NF-E2/genética , Estresse Oxidativo/efeitos dos fármacos , Extratos Vegetais/química , Extratos Vegetais/isolamento & purificação , Xantonas/química , Xantonas/isolamento & purificação
5.
J Physiol Biochem ; 70(1): 141-9, 2014 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-24037794

RESUMO

The present study was undertaken to investigate the effect of the new formyl peptide receptor 2/lipoxin A4 receptor agonist BML-111 on acetaminophen (APAP)-induced liver injury in mice and explore its possible mechanism(s). Male Swiss albino mice were intraperitoneally injected with BML-111 (1 mg/kg) twice daily for five consecutive days prior to a single intraperitoneal injection of APAP (500 mg/kg). Results have shown that APAP injection caused liver damage as indicated by significant increase in serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), and alkaline phosphatase (ALP). Liver histopathological examination revealed marked necrosis and inflammation. Additionally, APAP decreased activities of hepatic glutathione (GSH) and superoxide dismutase (SOD) with significant increase in the hepatic malondialdehyde (MDA) content. Furthermore, APAP increased serum nitrite/nitrate (NO(2) (-)/NO(3) (-)) level and hepatic tumor necrosis factor alpha (TNF-α). Pretreatment with BML-111 significantly reversed all APAP-induced pathological changes. BML-111 prevented the increase of AST, ALT, and ALP. Also, BML-111 markedly attenuated APAP-induced necrosis and inflammation. It decreased MDA with increase in SOD and GSH. Importantly, BML-111 decreased NO(2) (-)/NO(3) (-) level and TNF-α. These findings suggest that BML-111 has hepatoprotective effects against APAP-induced liver injury in mice. Its protective effect may be attributed to its ability to counteract the inflammatory ROS generation and regulate cytokine effects.


Assuntos
Doença Hepática Induzida por Substâncias e Drogas/prevenção & controle , Ácidos Heptanoicos/farmacologia , Acetaminofen , Alanina Transaminase/sangue , Fosfatase Alcalina/sangue , Animais , Aspartato Aminotransferases/sangue , Doença Hepática Induzida por Substâncias e Drogas/sangue , Avaliação Pré-Clínica de Medicamentos , Glutationa/metabolismo , Ácidos Heptanoicos/uso terapêutico , Fígado/efeitos dos fármacos , Fígado/enzimologia , Fígado/patologia , Masculino , Malondialdeído/metabolismo , Camundongos , Óxido Nítrico/sangue , Estresse Oxidativo , Superóxido Dismutase/metabolismo , Fator de Necrose Tumoral alfa/sangue
6.
J Physiol Biochem ; 70(1): 247-54, 2014 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-24234058

RESUMO

While propolis is known to have abundant bioactive constituents and a variety of biological activities, it is not clear whether propolis has beneficial effects on high glucose-mediated vascular endothelial impairment. The aim of the present study was to investigate the potential protective effect of propolis extract against the acute vascular endothelial dysfunction resulting from exposure to high glucose load and to elucidate its underlying mechanism. Rat aortic rings were incubated with normal glucose (11 mM), high glucose (44 mM), or mannitol (44 mM) for 3 h with or without propolis extract (400 µg/ml). Contraction to phenylephrine (Phe, 10(-9)-10(-5) M) and relaxation to acetylcholine (ACh, 10(-9)-10(-5) M) and sodium nitroprusside (SNP, 10(-9)-10(-5) M) were measured before and after incubation. Changes in malondialdehyde (MDA), reduced glutathione (GSH), and superoxide dismutase (SOD) were also measured. Phe-induced contraction was impaired by high glucose as the E(max) decreased from 138.87 ± 11.43 to 103.65 ± 11.5 %. In addition, ACh-induced relaxation was impaired as the E(max) decreased from 99.80 ± 7.25 to 39.20 ± 6.5 %. SNP-induced relaxation was not affected. Furthermore, high glucose decreased the levels of both SOD (by 6 U/ml) and GSH (by 68 %) and increased levels of MDA (by 85 %). Propolis extract prevented high glucose-induced impairment of Phe and ACh responses and increased both SOD and GSH, leading to decreased MDA levels. In conclusion, propolis can protect against high glucose-induced vascular dysfunction by reducing oxidative stress.


Assuntos
Antioxidantes/farmacologia , Endotélio Vascular/fisiopatologia , Glucose/toxicidade , Própole/farmacologia , Animais , Diabetes Mellitus/metabolismo , Avaliação Pré-Clínica de Medicamentos , Endotélio Vascular/efeitos dos fármacos , Glutationa/metabolismo , Técnicas In Vitro , Peroxidação de Lipídeos , Masculino , Estresse Oxidativo , Ratos , Ratos Sprague-Dawley , Superóxido Dismutase/metabolismo , Vasoconstrição , Vasodilatação
7.
Inflammopharmacology ; 19(6): 307-16, 2011 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-21947519

RESUMO

The present study was designed to examine the potential preventive and curative effects of curcumin, resveratrol, imatinib, rosiglitazone, losartan and bosentan (BOS) on Schistosoma mansoni-induced liver fibrosis in mice. Induction of liver fibrosis was produced in male Swiss mice by subcutaneous injection of S. mansoni cercariae per mouse. Mice were left for 28 days before starting the experiment then mice were divided into two main groups. The first group was further subdivided into experimental groups and started drug treatment at day 28 after infection and continued for 2 weeks in order to evaluate the potential preventive effects of the mentioned drugs on S. mansoni-induced liver fibrosis. The second group of mice were left for 2 weeks and then treated with praziquantel for two consecutive days to eradicate the worms and so stop egg disposition and further fibrosis development. Mice were then subdivided into the experimental groups and drug treatment was started for 2 weeks to evaluate their efficacy to decrease the developed fibrosis. At the end of the experiment period, mice were killed and serum was collected for the estimation of alanine aminotransferase (ALT), aspartate aminotransferase (AST), bilirubin and albumin. Liver tissue was taken for the estimation of hepatic hydroxyproline content and histopathological examination to confirm the biochemical results. Results of the study indicate that curcumin and imatinib have potent antifibrotic activity both in suppressing and reversing S. mansoni-induced liver fibrosis, while resveratrol has beneficial effects only in suppressing the development of S. mansoni-induced liver fibrosis.


Assuntos
Cirrose Hepática/tratamento farmacológico , Cirrose Hepática/prevenção & controle , Schistosoma mansoni/isolamento & purificação , Esquistossomose mansoni/patologia , Alanina Transaminase/sangue , Animais , Aspartato Aminotransferases/sangue , Benzamidas , Bilirrubina/sangue , Curcumina/farmacologia , Hidroxiprolina/metabolismo , Mesilato de Imatinib , Fígado/efeitos dos fármacos , Fígado/patologia , Cirrose Hepática/parasitologia , Cirrose Hepática/patologia , Masculino , Camundongos , Piperazinas/farmacologia , Pirimidinas/farmacologia , Resveratrol , Esquistossomose mansoni/sangue , Albumina Sérica/metabolismo , Estilbenos/farmacologia
8.
Arch Pharm Res ; 33(4): 637-43, 2010 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-20422375

RESUMO

Hypercholesterolemia, cholesterol-enriched diet and oxidative stress have been shown to increase serum total cholesterol (TC) and low density lipoprotein-cholesterol (LDL-C) levels resulting in development of atherosclerosis. Antioxidants play an important role in inhibiting and scavenging free radicals, thus providing protection to humans against infectious and degenerative diseases. The present study was undertaken to examine the possible protective effects of propolis (a resinous hive product collected by honeybees from various plant sources) and thymoquinone (TQ, active constituent of Nigella. Sativa seeds oil) on serum lipid levels and early atherosclerotic lesions in hypercholestrolemic rabbits. New Zealand rabbits were fed on either standard chow or atherogenic diet during four weeks and concomitantly received either propolis or TQ. At the end of experiment period, serum samples were collected to determine lipid profile, kidney functions and antioxidant status. Tissues from aorta, pulmonary artery and kidney were taken for histopathological examination. The cholesterol-enriched diet induced a significant increase in serum TC, triglycerides, LDL-C, thiobarbituric acid-reactive substances concentrations and a significant decrease in high density lipoprotein-cholesterol and in reduced glutathione levels compared to control group. Administration of propolis or TQ with cholesterol-enriched diet significantly (p < 0.05) reduced TC, LDL-C, triglycerides and thiobarbituric acid-reactive substances concentrations, while increased high density lipoprotein-cholesterol concentration, as well as glutathione content compared to high cholesterol (HC) control group. Kidney function parameters were significantly affected by cholesterol diet and both propolis and TQ counterregulated the cholesterol-induced changes. Histopathologically, early atherosclerotic changes were observed in HC control group represented by endothelial damage and thickened foam cells while propolis or TQ provided protection against the HC-induced damage. In conclusion, the present study suggests the potential beneficial effects of both propolis and TQ in diminishing the risk of atherosclerosis via antioxidant mechanism.


Assuntos
Antioxidantes/uso terapêutico , Aterosclerose/prevenção & controle , Benzoquinonas/uso terapêutico , Própole/uso terapêutico , Animais , Antioxidantes/administração & dosagem , Antioxidantes/metabolismo , Aorta/efeitos dos fármacos , Aorta/metabolismo , Aorta/patologia , Aterosclerose/etiologia , Aterosclerose/patologia , Benzoquinonas/administração & dosagem , Colesterol na Dieta/administração & dosagem , Colesterol na Dieta/efeitos adversos , Modelos Animais de Doenças , Rim/efeitos dos fármacos , Rim/metabolismo , Rim/patologia , Testes de Função Renal , Lipídeos/sangue , Masculino , Própole/administração & dosagem , Artéria Pulmonar/efeitos dos fármacos , Artéria Pulmonar/metabolismo , Artéria Pulmonar/patologia , Coelhos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA